Intrathecal Opioids for Colorectal Resection

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

February 17, 2023

Study Completion Date

February 17, 2023

Conditions
Colorectal SurgeryPain, PostoperativeAnalgesic, Opioid
Interventions
DRUG

Morphine

Dose titration utilizing will be done using sequential up and down design using biased coin method. All participant will receive a morphine dose that is within the range of doses currently utilized clinically and no participant will receive placebo only.

DRUG

Hydromorphone

Dose titration utilizing will be done using sequential up and down design using biased coin method. All participant will receive a hydromorphone dose that is within the range of doses currently utilized clinically and no participant will receive placebo only.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04752033 - Intrathecal Opioids for Colorectal Resection | Biotech Hunter | Biotech Hunter